6-[(6-Chloro-2-methylindazol-5-yl)amino]-3-[[1-(trideuteriomethyl)-1,2,4-triazol-3-yl]methyl]-1-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazine-2,4-dione

InChIKey	`QMPBBNUOBOFBFS-BMSJAHLVSA-N`
Compound Name	6-[(6-Chloro-2-methylindazol-5-yl)amino]-3-[[1-(trideuteriomethyl)-1,2,4-triazol-3-yl]methyl]-1-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazine-2,4-dione
Canonical SMILES	`[2H]C([2H])([2H])n1cnc(Cn2c(=O)[nH]/c(=N\c3cc4cn(C)nc4cc3Cl)n(Cc3cc(F)c(F)cc3F)c2=O)n1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	2
Pfam Stratification	Homologous
Avg pChEMBL	7.5
Source	BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P0DTD1	rep	Severe acute respiratory syndrome coronavirus 2	Pathogen	PF13087 PF16251 PF11501 PF12379 PF12124 PF11633 PF06471 PF06460 PF09401 PF20631 PF20633 PF20632 PF19215 PF19216 PF19219 PF19211 PF19218 PF16348 PF19217 PF19213 PF08716 PF08717 PF08710 PF08715 PF06478 PF01661 PF05409 PF00680	7.7	IC50	BindingDB
P0DTC1		Severe acute respiratory syndrome coronavirus 2	Pathogen	PF16251 PF11501 PF12379 PF12124 PF11633 PF09401 PF19211 PF19218 PF16348 PF19217 PF19213 PF08716 PF08717 PF08710 PF08715 PF01661 PF05409	7.3	IC50	BindingDB